185 related articles for article (PubMed ID: 12440854)
1. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy JA; Xu LC; Parker N; Vetzel M; Leamon CP
J Nucl Med; 2004 May; 45(5):857-66. PubMed ID: 15136637
[TBL] [Abstract][Full Text] [Related]
3. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
Ayala-López W; Xia W; Varghese B; Low PS
J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
[TBL] [Abstract][Full Text] [Related]
4. Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice.
Müller C; Reddy JA; Leamon CP; Schibli R
Mol Pharm; 2010 Apr; 7(2):597-604. PubMed ID: 20199053
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
Kim WH; Kim CG; Kim MH; Kim DW; Park CR; Park JY; Lee YS; Youn H; Kang KW; Jeong JM; Chung JK
Ann Nucl Med; 2016 Jun; 30(5):369-79. PubMed ID: 26993818
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
8. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.
Fisher RE; Siegel BA; Edell SL; Oyesiku NM; Morgenstern DE; Messmann RA; Amato RJ
J Nucl Med; 2008 Jun; 49(6):899-906. PubMed ID: 18483093
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Hubers D; Low PS; Green MA
Bioconjug Chem; 2000; 11(2):253-7. PubMed ID: 10725102
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of receptor-based tumor imaging agent: (99m)Tc-folate-glucaric acid.
Onursal M; Lambrecht FY; Ozgur A
Int J Pharm; 2011 Sep; 416(1):288-92. PubMed ID: 21782912
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
[TBL] [Abstract][Full Text] [Related]
12. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
13. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
14. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
15. A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery.
Kim MH; Kim SG; Kim DW
Ann Nucl Med; 2019 Aug; 33(8):606-616. PubMed ID: 31134434
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.
Müller C; Hohn A; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1007-16. PubMed ID: 16763819
[TBL] [Abstract][Full Text] [Related]
17. Imaging sites of infection using a 99mTc-labeled folate conjugate targeted to folate receptor positive macrophages.
Henne WA; Rothenbuhler R; Ayala-Lopez W; Xia W; Varghese B; Low PS
Mol Pharm; 2012 May; 9(5):1435-40. PubMed ID: 22468849
[TBL] [Abstract][Full Text] [Related]
18. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation.
Vaitilingam B; Chelvam V; Kularatne SA; Poh S; Ayala-Lopez W; Low PS
J Nucl Med; 2012 Jul; 53(7):1127-34. PubMed ID: 22693311
[TBL] [Abstract][Full Text] [Related]
19. Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers.
Kumar D; Sakhare N; Das S; Kale P; Mathur A; Mirapurkar S; Muralidharan S; Chaudhari P; Mohanty B; Ballal A; Patro P
Nucl Med Biol; 2021 Feb; 93():1-10. PubMed ID: 33212346
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-Tetraethylenepentamine-Folate--a new 99mTc-based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation.
Panwar P; Shrivastava V; Tandon V; Mishra P; Chuttani K; Sharma RK; Chandra R; Mishra AK
Cancer Biol Ther; 2004 Oct; 3(10):995-1001. PubMed ID: 15467429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]